LGT Financial Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22
| Closed | -$2.36K | – | 541 |
|
|
2024
Q4 | $2.36K | Hold |
22
| – | – | 0.01% | 670 |
|
|
2024
Q3 | $2.2K | Hold |
22
| – | – | 0.01% | 655 |
|
|
2024
Q2 | $1.85K | Hold |
22
| – | – | ﹤0.01% | 735 |
|
|
2024
Q1 | $1.61K | Hold |
22
| – | – | ﹤0.01% | 752 |
|
|
2023
Q4 | $1.57K | Hold |
22
| – | – | ﹤0.01% | 803 |
|
|
2023
Q3 | $1.32K | Buy |
+22
| New | +$1.32K | ﹤0.01% | 861 |
|